Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Hester Biosciences Limited ( (IN:HESTERBIO) ) has issued an announcement.
Hester Biosciences Limited announced that non-executive director Ravin Gandhi has resigned from the board with effect from 12 May 2026, citing professional and personal commitments that prevent him from devoting sufficient time to company affairs. As a result, alternate director Nina Gandhi has simultaneously ceased to hold office, and the company has clarified that there are no other material reasons for the resignation, underscoring a routine board change rather than a governance dispute.
The resignation, formally notified to the Bombay Stock Exchange and National Stock Exchange in line with SEBI disclosure norms, highlights Hester’s adherence to regulatory requirements and transparent communication with investors. While the departure removes an experienced board member and his alternate, the company has indicated continuity in operations and governance, seeking to reassure stakeholders that the change will not disrupt its strategic direction.
More about Hester Biosciences Limited
Hester Biosciences Limited operates in the biosciences and animal health sector, focusing on vaccines and related biological products for veterinary and potentially human use. The company is listed on Indian stock exchanges and maintains a governance structure that includes non-executive and alternate directors, reflecting its compliance with regulatory and listing requirements.
Average Trading Volume: 407
Technical Sentiment Signal: Hold
Current Market Cap: 14.03B INR
For a thorough assessment of HESTERBIO stock, go to TipRanks’ Stock Analysis page.